CD36 and chronic kidney disease: 1,25D3 may be contributing to alleviating CKD through inhibition of lipid metabolism in these cells by blocking PPARγ translocation to the nucleus, CD36 exposure on the cell surface, and TGF-β-mediated LB synthesis.